Tragus Stimulation for High BP; House Passes HEARTS Act; Risk in Pregnancy Surrogacy

Noninvasive, low‐level tragus stimulation modestly reduced blood pressure (BP) in relatively healthy people with grade 1 hypertension. (Journal of the American Heart Association)

The House passed the HEARTS Act, which would support CPR and automated external defibrillator training in schools. Now the bipartisan bill is headed to the Senate.

The PREVENT risk calculator can be recalibrated using artificial intelligence to be more accurate for local populations. (JAMA Cardiology)

Pregnancy surrogates face a higher risk of hypertension and other adverse pregnancy outcomes compared with women who carry their own pregnancies. (Annals of Internal Medicine)

Central and obstructive apnea are highly prevalent and predictive of mortality in those with transthyretin cardiac amyloidosis. (European Journal of Preventive Cardiology)

Following a positive opinion by a European regulatory body, expectations are building that the FDA will approve an expanded indication for semaglutide (Wegovy) in heart failure. (Barron’s)

A nationwide report found opportunities for more equitable hospital care quality for heart failure. (Circulation: Heart Failure)

Sustained ventricular arrhythmias occurring during the early post-infarction phase were predictive of recurrent arrhythmias and 1-year mortality. (European Heart Journal)

People with existing pacemakers did not clinically benefit from echocardiographic screening for left ventricular systolic dysfunction, though site type may matter based on the OPT-PACE trial. (Nature Medicine)

A global study found a growing burden of stroke due in part to increasing contributions from preventable environmental, metabolic, and behavioral risk factors. (Lancet Neurology)

Daily resveratrol supplements may help stabilize aortic growth in patients with Marfan syndrome. (Heart)

Researchers report good results from decades of complete vascular ring surgery at Boston Children’s Hospital. (Journal of the American College of Cardiology)

Congenital heart disease occurs disproportionately more often among people living in high altitudes, according to research highlighted by the American College of Cardiology.

In patients with type 2 diabetes and cancer, use of SGLT2 inhibitors was linked with a lower risk of cancer therapy-related cardiac dysfunction, a retrospective study showed. (JACC: CardioOncology)

For pulmonary arterial hypertension, upfront addition of selexipag (Uptravi) to double therapy was associated with reduced hospitalization and disease progression. (JAMA Network Open)

Please enable JavaScript to view the comments powered by Disqus.